Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Chen

Showing results (111-120 of 126) with videos related to

Pageof 13
Sort By:
Indoor Air|January 14, 2020
High concentrations of waste anesthetic gases induce genetic damage and inflammation in physicians exposed for three years: A cross-sectional studyMariana G Braz, Lorena I M Carvalho, Chung-Yen O Chen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 6, 2025
Whole genome sequencing-powered ctDNA sequencing for breast cancer detectionI Garcia-Murillas, C W Abbott, R J Cutts, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 18, 2025
Clinical and Translational Results from PORTER, a Multicohort Phase I Platform Trial of Combination Immunotherapy in Metastatic Castration-Resistant Prostate CancerMatthew D Galsky, Karen A Autio, Christopher R Cabanski, et al.
Oncotarget|March 14, 2024
Analytical validation of NeXT Personal®, an ultra-sensitive personalized circulating tumor DNA assayJosette Northcott, Gabor Bartha, Jason Harris, et al.
Oncotarget|June 20, 2024
Correction: Analytical validation of NeXT Personal®, an ultra-sensitive personalized circulating tumor DNA assayJosette Northcott, Gabor Bartha, Jason Harris, et al.
Clinical Genetics|December 3, 2014
Exome sequencing in 32 patients with anophthalmia/microphthalmia and developmental eye defectsA M Slavotinek, S T Garcia, G Chandratillake, et al.
JAMA Oncology|June 25, 2026
Neoadjuvant Paclitaxel, Trastuzumab, and Pertuzumab for Stage II to III, ERBB2-Positive Breast Cancer: A Secondary Analysis of the DAPHNe TrialPaolo Tarantino, Tianyu Li, Esther Ritah Ogayo, et al.
Medrxiv : the Preprint Server for Health Sciences|June 30, 2025
Diverse Genomes, Shared Health: Insights from a Health System BiobankRoni Haas, Michael P Margolis, Angela Wei, et al.
The Lancet. Oncology|January 2, 2021
CD40 agonistic monoclonal antibody APX005M (sotigalimab) and chemotherapy, with or without nivolumab, for the treatment of metastatic pancreatic adenocarcinoma: an open-label, multicentre, phase 1b studyMark H O'Hara, Eileen M O'Reilly, Gauri Varadhachary, et al.
Cell|March 28, 2026
Advancing precision health discovery in a genetically diverse health systemRoni Haas, Michael P Margolis, Angela Wei, et al.
Pageof 13

Showing results (111-120 of 126) with videos related to

Sort By:
Pageof 13
Indoor Air|January 14, 2020
High concentrations of waste anesthetic gases induce genetic damage and inflammation in physicians exposed for three years: A cross-sectional studyMariana G Braz, Lorena I M Carvalho, Chung-Yen O Chen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 6, 2025
Whole genome sequencing-powered ctDNA sequencing for breast cancer detectionI Garcia-Murillas, C W Abbott, R J Cutts, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 18, 2025
Clinical and Translational Results from PORTER, a Multicohort Phase I Platform Trial of Combination Immunotherapy in Metastatic Castration-Resistant Prostate CancerMatthew D Galsky, Karen A Autio, Christopher R Cabanski, et al.
Oncotarget|March 14, 2024
Analytical validation of NeXT Personal®, an ultra-sensitive personalized circulating tumor DNA assayJosette Northcott, Gabor Bartha, Jason Harris, et al.
Oncotarget|June 20, 2024
Correction: Analytical validation of NeXT Personal®, an ultra-sensitive personalized circulating tumor DNA assayJosette Northcott, Gabor Bartha, Jason Harris, et al.
Clinical Genetics|December 3, 2014
Exome sequencing in 32 patients with anophthalmia/microphthalmia and developmental eye defectsA M Slavotinek, S T Garcia, G Chandratillake, et al.
JAMA Oncology|June 25, 2026
Neoadjuvant Paclitaxel, Trastuzumab, and Pertuzumab for Stage II to III, ERBB2-Positive Breast Cancer: A Secondary Analysis of the DAPHNe TrialPaolo Tarantino, Tianyu Li, Esther Ritah Ogayo, et al.
Medrxiv : the Preprint Server for Health Sciences|June 30, 2025
Diverse Genomes, Shared Health: Insights from a Health System BiobankRoni Haas, Michael P Margolis, Angela Wei, et al.
The Lancet. Oncology|January 2, 2021
CD40 agonistic monoclonal antibody APX005M (sotigalimab) and chemotherapy, with or without nivolumab, for the treatment of metastatic pancreatic adenocarcinoma: an open-label, multicentre, phase 1b studyMark H O'Hara, Eileen M O'Reilly, Gauri Varadhachary, et al.
Cell|March 28, 2026
Advancing precision health discovery in a genetically diverse health systemRoni Haas, Michael P Margolis, Angela Wei, et al.
Pageof 13